ChemPartner PharmaTech Co Ltd (300149) — Financial Flexibility Index
ChemPartner PharmaTech Co Ltd (300149) has a Financial Flexibility Index of 0.09x as of June 2023. Free cash flow of CN¥94.83 Million (operating CF CN¥28.21 Million minus capex CN¥66.62 Million) represents 0% of total liabilities (CN¥1.06 Billion). Also explore ChemPartner PharmaTech Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ChemPartner PharmaTech Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for ChemPartner PharmaTech Co Ltd across 19 annual periods. Check ChemPartner PharmaTech Co Ltd (300149) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for ChemPartner PharmaTech Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for ChemPartner PharmaTech Co Ltd. For the full company profile including market capitalisation, see ChemPartner PharmaTech Co Ltd (300149) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.35x | CN¥252.97 Million | CN¥190.50 Million | CN¥732.59 Million | ▲ +10.2% |
| 2024 | 0.31x | CN¥237.45 Million | CN¥168.21 Million | CN¥757.75 Million | ▼ -13.4% |
| 2023 | 0.36x | CN¥352.28 Million | CN¥150.99 Million | CN¥973.44 Million | ▼ -13.1% |
| 2022 | 0.42x | CN¥598.66 Million | CN¥262.46 Million | CN¥1.44 Billion | ▲ +39.7% |
| 2021 | 0.30x | CN¥664.22 Million | CN¥378.22 Million | CN¥2.23 Billion | ▼ -32.5% |
| 2020 | 0.44x | CN¥737.19 Million | CN¥343.16 Million | CN¥1.67 Billion | ▲ +37.8% |
| 2019 | 0.32x | CN¥469.30 Million | CN¥215.07 Million | CN¥1.46 Billion | ▲ +3.8% |
| 2018 | 0.31x | CN¥353.07 Million | CN¥243.19 Million | CN¥1.14 Billion | ▼ -5.2% |
| 2017 | 0.33x | CN¥67.65 Million | CN¥63.43 Million | CN¥207.73 Million | ▼ -90.7% |
| 2016 | 3.52x | CN¥81.71 Million | CN¥71.26 Million | CN¥23.23 Million | ▼ -10.2% |
| 2015 | 3.91x | CN¥126.02 Million | CN¥100.69 Million | CN¥32.19 Million | ▲ +27.8% |
| 2014 | 3.06x | CN¥136.56 Million | CN¥59.63 Million | CN¥44.60 Million | ▼ -5.8% |
| 2013 | 3.25x | CN¥109.50 Million | CN¥46.32 Million | CN¥33.70 Million | ▼ -51.8% |
| 2012 | 6.74x | CN¥180.00 Million | CN¥55.09 Million | CN¥26.72 Million | ▲ +360.5% |
| 2011 | 1.46x | CN¥32.73 Million | CN¥11.66 Million | CN¥22.37 Million | ▼ -37.4% |
| 2010 | 2.34x | CN¥37.70 Million | CN¥20.81 Million | CN¥16.12 Million | ▲ +155.2% |
| 2009 | 0.92x | CN¥32.11 Million | CN¥13.28 Million | CN¥35.04 Million | ▼ -43.1% |
| 2008 | 1.61x | CN¥46.03 Million | CN¥21.70 Million | CN¥28.57 Million | ▲ +144.9% |
| 2007 | 0.66x | CN¥28.64 Million | CN¥22.19 Million | CN¥43.53 Million | — |